Dwyane Wade breaks down why the new salary cap rules are great for the NBA: "It forces teams to develop and make smarter financial decisions"
The incredible depth of the Oklahoma City Thunder roster, otherwise the second-youngest team in the league, was on full display in this year's playoffs, in what many are calling the strongest Western Conference in recent seasons.
Their playoff rotation included nine players averaging over 10 minutes per game, with seven of them playing over 20. When you have nine guys who can hold their own for 10 minutes on the court in an NBA playoff game, there's not much more to say.
On the other hand, to everyone's surprise, the Indiana Pacers were one win away from capturing their first-ever Larry O'Brien trophy. Their playoff rotation included 10 players, eight of whom were logging more than 15 minutes per game, with seven over the 20-minute mark.
All of this brings us to the conclusion that the NBA is slowly but surely entering a new era.
The era of superteams and superstar alliances is coming to an end.
The new salary cap rules are forcing teams to think differently. Teams are being built from the ground up because, under the new regulations, it's practically impossible to keep two max-contract players on the same roster long-term. That has created parity we've never seen before — the league crowned its seventh different champion in the past seven seasons, something that's never happened before. Dwyane Wade addressed this trend on the "The Why" podcast.
"It aimed at superteams or owners willing to spend endlessly," he said.
"It forces teams to develop and make smarter financial decisions. It makes it much harder to stack talent via free agency. So it's the Big 3 – we don't want this no more. If you go into the second apron, you can't use your mid-level exception to sign key players. These are the penalties. Then you can't package certain stars and trade for a star," he concluded.
The NBA is changing big time
Having ten players in a playoff rotation means one thing: you'll always have so-called "trade chips," which suggests the team won't fall apart quickly, like what's happening with the Denver Nuggets. Now, it's hard to say that the Nuggets have collapsed, considering they lost twice in a seven-game series after their championship season, and to outstanding teams.
However, aside from Nikola Jokic, Jamal Murray and Michael Porter Jr. received big contracts just before the new CBA rules were introduced. It's hard to blame Denver's front office — they couldn't have predicted how much the second apron would reshape roster building, but they had no room to put quality pieces around their main stars.
The Pacers, for example, have the luxury of Aaron Nesmith hitting five threes in the final five minutes of a playoff game and turning the impossible around against the New York Knicks. Eight total threes in the game. Not Tyrese Haliburton, not Pascal Siakam — Nesmith.
That's team depth.
The biggest takeaway from the success of the Thunder and the Pacers is that the NBA is changing big time and in a very specific direction: deeper rotations, less dependence on superstars and more balanced, well-constructed teams. Mark Cuban also broke down how the new CBA rules will impact the league.
"When you get past the second apron, it's even tougher and so before you could always figure out, you know, find a team together by making trades, taking back money, whatever it may be — that's going to be nearly impossible going forward," he said.The NBA is increasingly favoring roster depth and load distribution
In the 2005–06 season, 17 players averaged more than 40 minutes on the court, with starters usually playing between 40 and 44 minutes per game. Five years later, in the 2010–11 playoffs, that number dropped to ten, and the typical starter range moved to 39–41 minutes.
Today, in the 2024–25 season, only nine players are averaging more than 40 minutes in the playoffs; the average time for starters remains around 37–40 minutes and it's no longer standard for top players to routinely cross that threshold.
All of this confirms that the modern NBA is increasingly favoring roster depth and load distribution, as best demonstrated by the 2025 Finals teams.
So, expect teams in the coming seasons to be built in the image of the Pacers and Thunder. The new era has officially begun.This story was originally reported by Basketball Network on Jul 18, 2025, where it first appeared.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
AI and Automation Integration Elevates Laboratory Informatics Demand
The North America laboratory informatics market, valued at USD 1.62 billion in 2024, is set to grow at a CAGR of 4.30% to USD 2.48 billion by 2034. Growth is fueled by cloud-based LIMS, AI, and automation. Pharma and biotech sectors leverage informatics for efficiency, boosting the market with strategic partnerships. North American Laboratory Informatics Market Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "North America Laboratory Informatics Market Report and Forecast 2025-2034" has been added to offering. The North America laboratory informatics market was valued at USD 1.62 billion in 2024, driven by accelerating demand for cloud-based platforms. It is projected to grow at a CAGR of 4.30% from 2025 to 2034, reaching USD 2.48 billion by 2034. Informatics solutions, including LIMS, ELN, SDMS, and CDS, enhance data accuracy, compliance, and workflow automation in industries like pharmaceuticals and biotechnology. Innovations in cloud computing, AI, and automation are transforming laboratory data management by improving decision-making, regulatory compliance, and productivity. Market Growth Drivers and Trends Adoption of unified digital platforms is propelling market growth. The integration of LIMS and ELN functionalities enhances data security and collaboration. For example, eLabNext rebranded its key products into a centralised Digital Lab Platform in October 2024, aligning with market shifts toward streamlined management. The preference for advanced ELN systems is positively impacting market size. TeselaGen Biotechnology launched an enhanced ELN in December 2024, improving productivity and data management in biotech and pharmaceutical research. Global collaborations are strengthening market value. LabWare engaged with biopharma entities in Ireland in June 2024, facilitating knowledge exchange and technological advancements in LIMS adoption. Integration of AI and Automation The demand for AI-driven automation is elevating market demand. Funding initiatives support development in automated chemical laboratories, accelerating innovation and efficiency. By reducing manual errors, AI integrations boost LIMS and ELN system adoption, driving long-term market growth. Emerging Trends Cloud-Based LIMS: With significant IT sector contributions to GDP, cloud solutions are becoming essential for efficiency and compliance. Partnerships such as Revvity Signals Software with Scitara drive innovations in cloud-based platforms for R&D. AI and Automation: Initiatives like Scialog and LabVantage Solutions' integration of mixed reality demonstrate a shift towards AI-driven laboratory processes, enhancing efficiency and research competitiveness. Strategic Partnerships: Collaborations, such as those by LabVantage, are fuelling regulatory compliance and workflow automation, offering growth opportunities in laboratory informatics. Market Segmentation and Key Players: The market is segmented by product, delivery mode, component, end user, and region, with LIMS leading due to its pivotal role in sample management and workflow automation. Cloud solutions are preferred for scalability, while software advancements drive component value. Pharmaceutical companies hold the largest share, driven by stringent regulatory demands and R&D investments. Their adoption of informatics solutions enhances drug development and compliance. Major companies include Serum Institute of India, CSL Limited, Bharat Biotech, and CanSino Biologics, further shaping market dynamics with innovative solutions and global strategies. Region Analysis The United States dominates the market with strong R&D investments and digitalisation, while Canada shows growth due to government initiatives and cloud platform adoption. Both countries advance laboratory informatics with investments in data management and AI solutions. Conclusion The North America laboratory informatics market continues to grow, driven by technological advancements and strategic initiatives. The emphasis on AI, automation, and cloud solutions fosters efficiency and competition in the biotech, pharmaceutical, and research sectors. Key Attributes: Report Attribute Details No. of Pages 300 Forecast Period 2025 - 2034 Estimated Market Value (USD) in 2025 $1.62 Billion Forecasted Market Value (USD) by 2034 $2.48 Billion Compound Annual Growth Rate 4.3% Regions Covered North America For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Laboratory Informatics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
$515M Bet on Musk, AI, and Space: Glade Brook Goes All-In While Others Retreat
Glade Brook Capital Partners just pulled in $515 million for its fourth fund and it's placing its bets on the edge of what's next: AI, space, defense, and fintech. The firm, which already holds stakes in SpaceX, Stripe, and Elon Musk's Neuralink, plans to double down on late-stage tech startups navigating some of the most volatile capital markets in recent memory. Founder Paul Hudson didn't sugarcoat the conditions, calling it the most challenging fundraising environment he's seen in his career even as the fund ended up oversubscribed. Despite the headwinds, Glade Brook is leaning into momentum. It's already backing Musk's xAI and Artisan AI, signaling a clear tilt toward artificial intelligence. That comes on top of a portfolio that includes ramping fintech player Ramp and previously backed giants like Uber (NYSE:UBER) and Airbnb (NASDAQ:ABNB). And in a move that tracks closely with broader market appetite, the firm is betting that innovation in complex, capital-intensive sectors like AI and defense could offer asymmetric upside if timed right. Tesla (NASDAQ:TSLA) remains part of the broader Musk-aligned orbit Glade Brook is exposed to, adding even more edge to its late-stage tech focus. Their 2021 fund a $430 million vehicle reportedly ranks in the top 5% of its vintage, according to private Cambridge Associates data. While past performance doesn't guarantee future returns, it does suggest Glade Brook knows how to play late-stage cycles. In a market where many VCs are stuck in wait-and-see mode, Glade Brook appears to be playing offense betting that when the next wave breaks, it'll be the firms already in position that ride it the farthest. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo
24 minutes ago
- Yahoo
Mariners and Brewers meet to determine series winner
Milwaukee Brewers (60-41, second in the NL Central) vs. Seattle Mariners (54-47, second in the AL West) Seattle; Wednesday, 3:40 p.m. EDT PITCHING PROBABLES: Brewers: Quinn Priester (8-2, 3.33 ERA, 1.20 WHIP, 80 strikeouts); Mariners: Luis Castillo (7-5, 3.21 ERA, 1.21 WHIP, 100 strikeouts) BETMGM SPORTSBOOK LINE: Mariners -132, Brewers +112; over/under is 6 1/2 runs BOTTOM LINE: Both the Seattle Mariners and the Milwaukee Brewers are looking for a series win with a victory on Wednesday. Seattle is 54-47 overall and 28-23 at home. The Mariners have hit 139 total home runs to rank third in the AL. Milwaukee has a 27-24 record in road games and a 60-41 record overall. Brewers hitters are batting a collective .249, which ranks seventh in the NL. Wednesday's game is the third time these teams match up this season. TOP PERFORMERS: Cal Raleigh leads the Mariners with 55 extra base hits (16 doubles and 39 home runs). Randy Arozarena is 11 for 39 with three doubles, four home runs and seven RBIs over the last 10 games. Christian Yelich leads the Brewers with 19 home runs while slugging .450. Jackson Chourio is 14 for 41 with two doubles, a home run and nine RBIs over the last 10 games. LAST 10 GAMES: Mariners: 6-4, .257 batting average, 4.54 ERA, outscored opponents by 10 runs Brewers: 9-1, .266 batting average, 2.40 ERA, outscored opponents by 25 runs INJURIES: Mariners: Bryce Miller: 15-Day IL (elbow), Collin Snider: 15-Day IL (forearm), Gregory Santos: 60-Day IL (knee), Victor Robles: 60-Day IL (shoulder), Ryan Bliss: 60-Day IL (biceps) Brewers: Jake Bauers: 10-Day IL (shoulder), Sal Frelick: 10-Day IL (hamstring), Rhys Hoskins: 10-Day IL (thumb), Garrett Mitchell: 60-Day IL (oblique), Rob Zastryzny: 15-Day IL (ribs), Connor Thomas: 60-Day IL (elbow), Nestor Cortes: 60-Day IL (elbow), Robert Gasser: 60-Day IL (elbow) ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.